Kala Pharmaceuticals Inc. Stock
There is an upward development for Kala Pharmaceuticals Inc. compared to yesterday, with an increase of €0.13 (2.130%).
Currently there is a rather positive sentiment for Kala Pharmaceuticals Inc. with 4 Buy predictions and 0 Sell predictions.
Based on the current price of 6.22 € the target price of 19 € shows a potential of 205.47% for Kala Pharmaceuticals Inc. which would more than double the current price.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Kala Pharmaceuticals Inc. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Kala Pharmaceuticals Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
S********** s********
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Kala Pharmaceuticals Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Kala Pharmaceuticals Inc. | 2.130% | 8.174% | -9.395% | -54.130% | -4.601% | -97.475% | - |
| Ardelyx Inc. | 28.120% | 34.723% | 16.633% | 93.717% | 39.758% | 44.250% | - |
| Evolus Inc | 4.240% | 17.143% | 2.500% | 61.842% | 35.912% | 68.493% | - |
| Salarius Pharmaceuticals Inc. | -1.300% | 6.573% | 5.581% | -68.472% | -18.198% | -98.220% | -99.993% |
Comments
KALA BIO, Inc. (NASDAQ: KALA) had its price target lowered by analysts at HC Wainwright from $22.00 to $21.00. They now have a "buy" rating on the stock.
Show more
Ratings data for KALA provided by MarketBeat
KALA BIO, Inc. (NASDAQ: KALA) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $15.00 price target on the stock.
Show more
Ratings data for KALA provided by MarketBeat
KALA BIO, Inc. (NASDAQ: KALA) had its price target lowered by analysts at HC Wainwright from $24.00 to $22.00. They now have a "buy" rating on the stock.
Show more
Ratings data for KALA provided by MarketBeat